statistiche ricercatore

Continente	#
NA - Nord America	895
EU - Europa	745
AS - Asia	324
SA - Sud America	76
Continente sconosciuto - Info sul continente non disponibili	28
AF - Africa	23
Totale	2.091

Nazione	#
US - Stati Uniti d'America	874
RU - Federazione Russa	218
SG - Singapore	125
IE - Irlanda	112
IT - Italia	103
GB - Regno Unito	77
CN - Cina	72
SE - Svezia	61
BR - Brasile	56
VN - Vietnam	43
DE - Germania	40
FR - Francia	40
HK - Hong Kong	30
FI - Finlandia	27
UA - Ucraina	27
IN - India	26
ES - Italia	13
ZA - Sudafrica	13
CA - Canada	11
AR - Argentina	7
KR - Corea	6
NL - Olanda	6
MA - Marocco	5
BD - Bangladesh	4
CZ - Repubblica Ceca	4
IQ - Iraq	4
PL - Polonia	4
TR - Turchia	4
CO - Colombia	3
VE - Venezuela	3
AT - Austria	2
BO - Bolivia	2
CI - Costa d'Avorio	2
CR - Costa Rica	2
EC - Ecuador	2
KE - Kenya	2
PT - Portogallo	2
SK - Slovacchia (Repubblica Slovacca)	2
BB - Barbados	1
BY - Bielorussia	1
CL - Cile	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
GP - Guadalupe	1
GT - Guatemala	1
GY - Guiana	1
HN - Honduras	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JP - Giappone	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
LU - Lussemburgo	1
MN - Mongolia	1
MT - Malta	1
MX - Messico	1
NP - Nepal	1
OM - Oman	1
PR - Porto Rico	1
PY - Paraguay	1
RO - Romania	1
RS - Serbia	1
SV - El Salvador	1
TH - Thailandia	1
UZ - Uzbekistan	1
Totale	2.063

Nome	#
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up	240
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC	236
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up	219
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?	213
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients	185
Stato nutrizionale e risposta al trattamento con inibitori tirosino-chinasici nel carcinoma tiroideo avanzato	173
Improvement of overall survival using TKIs as salvage therapy in advanced thyroid carcinoma: Real‐life data on a single center experience	165
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels	159
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients	138
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up	132
Thyroid cancer- A case-Based Approach	118
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up	113
Totale	2.091

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	67	0	0	0	0	3	6	3	5	1	13	15	21
2022/2023	177	11	21	28	16	8	40	4	17	17	11	4	0
2023/2024	162	4	5	17	3	6	35	66	1	4	0	2	19
2024/2025	353	6	16	47	18	47	30	6	10	44	10	43	76
2025/2026	805	63	82	61	128	162	29	104	20	28	32	27	69
2026/2027	135	39	14	44	26	12	0	0	0	0	0	0	0
Totale													2.091